8082-737-676
Kalkine 0
countryflagUK
Log

0R15 7172.0 -4.284% 0R1E 10080.0 -3.263% 0M69 None None% 0R2V 206.0 -8.2814% 0QYR 1608.0 -7.4266% 0QYP 374.2 -2.1699% 0RUK None None% 0RYA 1551.0 -2.2684% 0RIH 156.5 -0.5402% 0RIH 152.0 -2.8754% 0R1O 180.2 9265.9044% 0R1O None None% 0QFP 10450.0 107.3413% 0M2Z 279.7562 -0.1879% 0VSO 44.63 25.3476% 0R1I None None% 0QZI 587.0 0.8591% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 158.85 -6.9129%
0R15 7172.0 -4.284% 0R1E 10080.0 -3.263% 0M69 None None% 0R2V 206.0 -8.2814% 0QYR 1608.0 -7.4266% 0QYP 374.2 -2.1699% 0RUK None None% 0RYA 1551.0 -2.2684% 0RIH 156.5 -0.5402% 0RIH 152.0 -2.8754% 0R1O 180.2 9265.9044% 0R1O None None% 0QFP 10450.0 107.3413% 0M2Z 279.7562 -0.1879% 0VSO 44.63 25.3476% 0R1I None None% 0QZI 587.0 0.8591% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 158.85 -6.9129%

Cardinal Health Inc

Healthcare US CAH

136.12USD
-2.55(1.84%)

Last update at 2025-04-03T16:53:00Z

Day Range

135.98139.50
LowHigh

52 Week Range

67.33108.85
LowHigh

Fundamentals

  • Previous Close 138.67
  • Market Cap24974.60M
  • Volume1326297
  • P/E Ratio166.11
  • Dividend Yield1.98%
  • EBITDA2624.00M
  • Revenue TTM210172.00M
  • Revenue Per Share TTM822.59
  • Gross Profit TTM 6545.00M
  • Diluted EPS TTM0.61

Analyst Recommendations

Financials

Income Statement

2019-06-302020-06-302021-06-302022-06-302023-06-300M20000M40000M60000M80000M100000M120000M140000M160000M180000M200000M
Total Revenue
Net Income

Balancesheet

2019-06-302020-06-302021-06-302022-06-302023-06-300M5000M10000M15000M20000M25000M30000M35000M40000M45000M
Total Assets
Total Liabilities

Change in Cash

2019-06-302020-06-302021-06-302022-06-302023-06-30-600M-400M-200M0M200M400M600M800M1000M1200M

Total Operating Cash

2019-06-302020-06-302021-06-302022-06-302023-06-301900M2000M2100M2200M2300M2400M2500M2600M2700M2800M2900M3000M3100M3200M

Dividends Paid

2019-06-302020-06-302021-06-302022-06-302023-06-300M50M100M150M200M250M300M350M400M450M500M550M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax 638.00M -769.00000M 323.00M -3772.00000M 1751.00M
Minority interest -1.00000M 1.00M 3.00M 3.00M 2.00M
Net income 261.00M -932.00000M 611.00M -3693.00000M 1363.00M
Selling general administrative 4834.00M 4557.00M 4533.00M 4572.00M 4480.00M
Selling and marketing expenses 4834.00M 4557.00M 4533.00M - -
Gross profit 6889.00M 6545.00M 6778.00M 6868.00M 6834.00M
Reconciled depreciation 692.00M 692.00M 783.00M 913.00M 1000.00M
Ebit 1774.00M 1648.00M 1841.00M 1773.00M 2060.00M
Ebitda 2466.00M 2340.00M 2624.00M 2686.00M 2718.00M
Depreciation and amortization 692.00M 692.00M 783.00M 913.00M 658.00M
Non operating income net other 4.00M -24.00000M 31.00M -15.00000M -15.00000M
Operating income 727.00M 1648.00M 1841.00M 1773.00M 2060.00M
Other operating expenses 203242.00M 179700.00M 160673.00M 151150.00M 143801.00M
Interest expense 93.00M 149.00M 180.00M 238.00M 294.00M
Tax provision 376.00M 163.00M -289.00000M -79.00000M 386.00M
Interest income 93.00M 147.00M 182.00M 341.00M 307.00M
Net interest income -93.00000M -149.00000M -180.00000M -238.00000M -294.00000M
Extraordinary items - - - - -
Non recurring 1043.00M 2260.00M 1322.00M 5870.00M -327.00000M
Other items - - - - -
Income tax expense 376.00M 163.00M -289.00000M -79.00000M 386.00M
Total revenue 205012.00M 181364.00M 162467.00M 152922.00M 145534.00M
Total operating expenses 5119.00M 4881.00M 4984.00M 5096.00M 5101.00M
Cost of revenue 198123.00M 174819.00M 155689.00M 146054.00M 138700.00M
Total other income expense net -1039.00000M -2417.00000M -1518.00000M -5545.00000M -309.00000M
Discontinued operations - - - - -
Net income from continuing ops 262.00M -932.00000M 612.00M -3693.00000M 2137.00M
Net income applicable to common shares 261.00M -933.00000M 611.00M -3696.00000M 1363.00M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 43417.00M 43878.00M 44453.00M 40766.00M 40963.00M
Intangible assets 1472.00M 1774.00M 2105.00M 2918.00M 3430.00M
Earning assets - - - - -
Other current assets 2362.00M 2021.00M 3944.00M 1707.00M 1946.00M
Total liab 46268.00M 44584.00M 42659.00M 38974.00M 34633.00M
Total stockholder equity -2851.00000M -706.00000M 1794.00M 1792.00M 6330.00M
Deferred long term liab 8653.00M 9299.00M 9670.00M 8594.00M 2945.00M
Other current liab 42.00M 2842.00M 96.00M 2231.00M 2122.00M
Common stock 2747.00M 2813.00M 2806.00M 2789.00M 2763.00M
Capital stock 2747.00M 2813.00M 2806.00M 2789.00M 2763.00M
Retained earnings -534.00000M -280.00000M 1205.00M 1170.00M 5434.00M
Other liab 8278.00M 9299.00M 9670.00M 8237.00M 2939.00M
Good will 4609.00M 5855.00M 7989.00M 8357.00M 8378.00M
Other assets 606.00M 953.00M 951.00M 732.00M 1006.00M
Cash 4043.00M 4717.00M 3407.00M 2771.00M 2531.00M
Cash and equivalents 4043.00M 4717.00M 3407.00M 2771.00M 2531.00M
Total current liabilities 33706.00M 30550.00M 27624.00M 23615.00M 24109.00M
Current deferred revenue 3059.00M - 2957.00M - -
Net debt 658.00M 598.00M 2829.00M 4004.00M 5500.00M
Short term debt 792.00M 580.00M 871.00M 10.00M 452.00M
Short long term debt 792.00M 580.00M 871.00M 10.00M 452.00M
Short long term debt total 4701.00M 5315.00M 6236.00M 6775.00M 8031.00M
Other stockholder equity -4913.00000M -3125.00000M -2183.00000M -2063.00000M -1788.00000M
Property plant equipment 2462.00M 2361.00M 2360.00M 2792.00M 2356.00M
Total current assets 33833.00M 32935.00M 31048.00M 25940.00M 25747.00M
Long term investments - - - - 46.00M
Net tangible assets -8933.00000M -8338.00000M -8300.00000M -9486.00000M -5480.00000M
Short term investments - - - - -
Net receivables 11344.00M 10561.00M 9103.00M 8264.00M 8448.00M
Long term debt 3909.00M 4735.00M 5365.00M 6740.00M 7579.00M
Inventory 15940.00M 15636.00M 14594.00M 13198.00M 12822.00M
Accounts payable 29813.00M 27128.00M 23700.00M 21374.00M 21535.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity 1.00M 3.00M 3.00M 3.00M 2.00M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -151.00000M -114.00000M -34.00000M -104.00000M -79.00000M
Additional paid in capital - - - - -
Common stock total equity 2747.00M 2813.00M 2806.00M 2789.00M 2763.00M
Preferred stock total equity - - - - -
Retained earnings total equity -534.00000M -280.00000M 1205.00M 1170.00M 5434.00M
Treasury stock -4914.00000M -3128.00000M -2186.00000M -2066.00000M -1790.00000M
Accumulated amortization - - - - -
Non currrent assets other 1041.00M -8346.00000M 951.00M 1185.00M 1052.00M
Deferred long term asset charges - - - - -
Non current assets total 9584.00M 10943.00M 13405.00M 14826.00M 15216.00M
Capital lease obligations - - - - -
Long term debt total 3909.00M 4735.00M 5365.00M 6765.00M 7579.00M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -454.00000M 22.00M 25.00M 866.00M -15.00000M
Change to liabilities 2718.00M 3428.00M 2325.00M -162.00000M 1864.00M
Total cashflows from investing activities -454.00000M 567.00M -378.00000M 493.00M 338.00M
Net borrowings -579.00000M -885.00000M -570.00000M -1401.00000M -1102.00000M
Total cash from financing activities -3051.00000M -2463.00000M -1317.00000M -2200.00000M -2293.00000M
Change to operating activities - 293.00M 452.00M 6550.00M 193.00M
Net income 262.00M -932.00000M 612.00M -3693.00000M 1365.00M
Change in cash -674.00000M 1310.00M 636.00M 240.00M 768.00M
Begin period cash flow 4717.00M 3407.00M 2771.00M 2531.00M 1763.00M
End period cash flow 4043.00M 4717.00M 3407.00M 2771.00M 2531.00M
Total cash from operating activities 2839.00M 3122.00M 2429.00M 1960.00M 2722.00M
Issuance of capital stock - - - - -
Depreciation 692.00M 692.00M 783.00M 913.00M 1000.00M
Other cashflows from investing activities 2.00M 932.00M 22.00M 2.00M 681.00M
Dividends paid 525.00M 559.00M 573.00M 569.00M 577.00M
Change to inventory -340.00000M -1071.00000M -1584.00000M -409.00000M -551.00000M
Change to account receivables -947.00000M -1526.00000M -904.00000M 82.00M -751.00000M
Sale purchase of stock -2000.00000M -1000.00000M -200.00000M -350.00000M -600.00000M
Other cashflows from financing activities 53.00M -19.00000M 26.00M 120.00M -14.00000M
Change to netincome 1421.00M 2238.00M 746.00M -1321.00000M -401.00000M
Capital expenditures 481.00M 387.00M 400.00M 375.00M 328.00M
Change receivables -947.00000M -1526.00000M -904.00000M 82.00M -751.00000M
Cash flows other operating -967.00000M 293.00M 452.00M 6550.00M 196.00M
Exchange rate changes - - 11.00M -13.00000M 1.00M
Cash and cash equivalents changes -666.00000M 1226.00M 745.00M 240.00M 768.00M
Change in working capital 464.00M 1124.00M 289.00M 6061.00M 755.00M
Stock based compensation 96.00M 81.00M 89.00M 90.00M 82.00M
Other non cash items 1356.00M 2150.00M 160.00M -450.00000M -397.00000M
Free cash flow 2358.00M 2735.00M 2029.00M 1585.00M 2394.00M

Peer Comparison

Sector: Healthcare Industry: Medical Distribution

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CAH
Cardinal Health Inc		 -2.55 1.84% 136.12 166.11 14.71 0.12 16.07 0.12 19.78
MCK
McKesson Corporation		 20.96 3.02% 714.49 17.95 14.53 0.20 5.04 0.22 12.17
COR
Cencora Inc.		 7.80 2.79% 287.31 23.39 - - -
HSIC
Henry Schein Inc		 -2.05 2.96% 67.20 24.12 14.04 0.74 2.50 0.95 13.33
SHPMF
Shanghai Pharmaceuticals Holding Co. Ltd		 - -% 1.56 7.71 5.45 0.03 0.57 0.03 0.88

Reports Covered

Stock Research & News

View All

Profile

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Cardinal Health Inc

7000 Cardinal Place, Dublin, OH, United States, 43017

Key Executives

Name Title Year Born
Mr. Jason M. Hollar CEO & Director 1973
Ms. Jessica L. Mayer Chief Legal & Compliance Officer 1970
Mr. Stephen M. Mason Chief Exec. Officer of Medical Segment 1972
Ms. Patricia M. English Sr. VP & Interim CFO 1980
Ms. Mary C. Scherer Sr. VP & Chief Accounting Officer NA
Ms. Michelle Greene Exec. VP & Chief Information Officer and Global Bus. Services NA
Mr. Kevin Moran VP of Investor Relations NA
Ms. Ola M. Snow Chief HR Officer 1968
Mr. Craig Cowman Exec. VP of Strategic Sourcing & Manufacturer Services NA
Ms. Deborah L. Weitzman Chief Exec. Officer of Pharmaceutical Distribution NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions